Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30
Closed -$6.34K 275
2024
Q2
$6.34K Sell
30
-64
-68% -$14.5K ﹤0.01% 329
2024
Q1
$23.8K Sell
94
-74
-44% -$17.3K ﹤0.01% 267
2023
Q4
$38.9K Hold
168
0.01% 256
2023
Q3
$33.1K Sell
168
-77
-31% -$16.7K 0.01% 246
2023
Q2
$55.1K Hold
245
0.01% 220
2023
Q1
$48.7K Sell
245
-29
-11% -$6.2K 0.01% 227
2022
Q4
$56.1K Buy
274
+26
+10% +$5.27K 0.01% 227
2022
Q3
$45K Sell
248
-712
-74% -$156K 0.01% 224
2022
Q2
$208K Sell
960
-319
-25% -$69.3K 0.04% 174
2022
Q1
$296K Buy
1,279
+459
+56% +$109K 0.05% 154
2021
Q4
$231K Buy
820
+288
+54% +$74.7K 0.04% 164
2021
Q3
$127K Buy
532
+474
+817% +$120K 0.02% 182
2021
Q2
$14K Buy
+58
New +$13.4K ﹤0.01% 259

Other funds holding IQV

Central Bank & Trust's IQV Position: Q3 2024 in Review

Central Bank & Trust sold out of IQVIA (IQV) in Q3 2024, closing a stake of 30 shares — an estimated $6.34K sold.

Central Bank & Trust first reported a position in IQV in Q2 2021 and held it in 13 quarters. The position peaked at $296K in Q1 2022. 1,060 funds tracked by Wall St. Rank hold IQV as of Q3 2024.

  • Central Bank & Trust reported no remaining IQVIA position as of Q3 2024 after selling out during the quarter.
  • Central Bank & Trust sold 30 IQVIA shares in Q3 2024, an estimated $6.34K.
  • Central Bank & Trust first reported a position in IQVIA in Q2 2021 and held it in 13 quarters.
  • Central Bank & Trust's IQVIA position peaked at $296K in Q1 2022.
  • 1,060 funds tracked by Wall St. Rank held IQVIA as of Q3 2024.

Based on Central Bank & Trust's 13F filing for Q3 2024, filed 30 Oct 2024.